Explore the latest in acute coronary syndromes, including recent guidelines and advances in management of STEMI, NSTEMI, and unstable angina.
This editorial comments on recent data that show a mortality gap between individuals with and without schizophrenia, with changes in the disparity as the amount of medical care given increases.
This study uses the Danish nationwide health care registries to investigate the association of secondary preventive cardiovascular treatment with all-cause mortality after myocardial infarction in patients with schizophrenia compared with those without schizophrenia.
This cross-sectional study examines 30-day risk-standardized mortality rates for coronary artery bypass grafting, acute myocardial infarction, and heart failure at top-ranked US News & World Report cardiology vs nonranked hospitals.
This cohort study determines the rate of return to work among Chinese patients within 12 months after acute myocardial infarction, classifies the reasons why patients did not return to work, and identifies patient factors associated with returning to work after acute myocardial infarction.
A 36-year-old gravida 3, para 3 woman who had elective cesarean delivery 11 days prior presented with 3 days of exertional chest pain, an elevated troponin I level, ST-segment depression on electrocardiography, and coronary artery dissection on angiography. What would you do next?
This secondary analysis of a randomized clinical trial assesses if different biomarkers provide information about the risk for all-cause and cause-specific mortality after acute coronary syndrome.
This cohort study uses data from 2 US myocardial infarction registries to assess whether demographic or clinical characteristics differ between self-identified black patients and white patients or are associated with 1- or 5-year survival after acute myocardial infarction.
This cohort study of community-dwelling, elderly individuals in Iceland examines the association of unrecognized myocardial infarction by cardiovascular magnetic resonance imaging with major adverse cardiac events, such as death, nonfatal myocardial infarction, and heart failure.
This cohort study compares the efficacy of a novel point-of-care troponin assay with an established assay in patients with possible acute myocardial infarction.
This secondary analysis of a randomized clinical trial investigates whether periprocedural loading doses of atorvastatin are associated with decreased 30-day major adverse cardiovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
This cohort study examines the incidence, trends, and hospital variation in same-day discharge and its association with readmissions for bleeding, acute kidney injury, acute myocardial infarction, or mortality in the United States.
This population-based study investigates whether weather is associated with day-to-day incidence of myocardial infarction in Sweden.
This Patient Page describes candidates for cardiac rehabilitation and how it can help treat cardiovascular disease.
This cross-sectional study investigates the association between hospital-level 30-day risk-standardized mortality rates and 30-day risk-standardized payments for acute myocardial infarction (MI), heart failure, and pneumonia among Medicare fee-for-service beneficiaries.
This cohort study uses Medicare data to evaluate whether the announcement or implementation of the Hospital Readmissions Reduction Program (HRRP) was associated with an increase in either in-hospital or 30-day postdischarge mortality following hospitalization for acute myocardial infarction (AMI), heart failure (HF), or pneumonia.
This cohort study examines the risk for cardiovascular disease among women in Denmark who have given birth to children with major congenital anomalies.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: